| eltoprazine (DU 28853) / Amarantus BioSci, PsychoGenics, ReqMed |
NCT01266174: Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults |
|
|
| Completed | 2 | 31 | US | Eltoprazine, eltropazine hydrochloride, Placebo | Amarantus BioScience Holdings, Inc. | Cognitive Impairment, Schizophrenia | 09/12 | 11/12 | | |
2009-015928-28: A double-blind, randomized, placebo controlled, dose finding study of oral eltoprazine for treatment of levodopa-induced dyskinesias (LID) in a levodopa challenge-dose setting in Parkinsons Disease. |
|
|
| | 2 | 24 | Europe | Eltoprazine HCl, Eltoprazine HCl, | PsychoGenics Inc | Dyskinesias related to levodopa treatment in Parkinson´s disease | | | | |
NCT02439125 / 2015-000373-13: A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients |
|
|
| Unknown status | 2 | 60 | US | Eltoprazine HCl, Placebo | Amarantus BioScience Holdings, Inc. | Parkinson's Disease, Dyskinesia | 06/17 | 12/17 | | |
